Title of Collaborative Activity: |
HHS Viral Hepatitis Interagency Working Group |
Description of Collaborative Activity: |
The Department of Health and Human Services (HHS) Viral Hepatitis Interagency Working Group was created by the Office of the Assistant Secretary for Health to address a report sponsored by the Institute of Medicine entitled Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. The group meets to discuss collaborations and activities directed at achieving the goals for viral hepatitis research and control highlighted in the IOM report. (Although the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute on Drug Abuse (NIDA) represent the National Institutes of Health (NIH) as Working Group members, other NIH Institutes/Centers/Offices also provide input to the VHIG through their participation in the Trans-NIH Committee on Viral Hepatitis.) The working group helped develop the 2021-2025 Viral Hepatitis National Strategic Plan. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2009 |
NIH Participating Institutes/Centers/Office of the Director: |
NIDA, NIAID, NIDDK, OD/DPCPSI/OAR |
HHS Agency Collaborators on this Activity: |
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA |
